Related Experiment Video

Updated: Jul 5, 2026

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Caveats of caveolin-1 in cancer progression

Elke Burgermeister1, Mordechai Liscovitch, Christoph Röcken

  • 1Department of Medicine II, Klinikum Rechts der Isar, Technical University of München, München, Germany. elke.burgermeister@lrz.tum.de

Cancer Letters
|May 17, 2008
PubMed

Insights

Caveolin-1 acts as a tumor suppressor in normal tissues but promotes metastasis and angiogenesis in advanced cancers. Its expression levels indicate cancer stage and drug resistance, offering prognostic value.

Area of Science:

  • Molecular biology
  • Cell biology
  • Cancer research

Background:

  • Caveolin-1 is a key protein in caveolae and cellular transport.
  • It functions as a tumor suppressor in non-neoplastic tissues.
  • Caveolin-1 expression is altered during cancer development and progression.

Purpose of the Study:

  • To review the dual role of caveolin-1 in cancer.
  • To focus on caveolin-1's involvement in metastasis and angiogenesis.
  • To explore its clinical significance as a prognostic marker.

Main Methods:

  • Literature review of patient studies and rodent models.
  • Analysis of caveolin-1's function in different cancer stages.
  • Examination of its correlation with metastasis, angiogenesis, and drug resistance.

Main Results:

  • Caveolin-1 acts as a tumor suppressor in normal tissues, with its loss of function upon transformation.
  • Re-expression of caveolin-1 is observed in advanced, metastatic, and multidrug-resistant tumors.
  • Caveolin-1 plays a significant role in promoting tumor metastasis and angiogenesis.

Conclusions:

  • Caveolin-1 exhibits context-dependent roles in cancer progression.
  • Its expression pattern is a valuable indicator for predicting cancer metastasis and drug resistance.
  • Caveolin-1 holds potential as a prognostic marker for cancer patients.

More Related Videos

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...